393 related articles for article (PubMed ID: 31931789)
1. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
de Boer PT; Backer JA; van Hoek AJ; Wallinga J
BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.
Zeevat F; Crépey P; Dolk FCK; Postma AJ; Breeveld-Dwarkasing VNA; Postma MJ
Value Health; 2021 Jan; 24(1):3-10. PubMed ID: 33431150
[TBL] [Abstract][Full Text] [Related]
5. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
Brydak L; Roiz J; Faivre P; Reygrobellet C
Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
Naber SK; Bruijning-Verhagen PCJL; de Hoog MLA; van Giessen A
Vaccine; 2020 Apr; 38(17):3387-3396. PubMed ID: 32115297
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
[TBL] [Abstract][Full Text] [Related]
8. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
Baguelin M; Camacho A; Flasche S; Edmunds WJ
BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.
Leung MK; You JH
Vaccine; 2016 May; 34(22):2469-76. PubMed ID: 27079928
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
Edoka I; Kohli-Lynch C; Fraser H; Hofman K; Tempia S; McMorrow M; Ramkrishna W; Lambach P; Hutubessy R; Cohen C
Vaccine; 2021 Jan; 39(2):412-422. PubMed ID: 33272702
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age.
Kittikraisak W; Suntarattiwong P; Ditsungnoen D; Pallas SE; Abimbola TO; Klungthong C; Fernandez S; Srisarang S; Chotpitayasunondh T; Dawood FS; Olsen SJ; Lindblade KA
PLoS One; 2017; 12(8):e0183391. PubMed ID: 28837594
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
Meier G; Gregg M; Poulsen Nautrup B
J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study.
Yue M; Dickens BL; Yoong JS; I-Cheng Chen M; Teerawattananon Y; Cook AR
Value Health; 2019 Dec; 22(12):1345-1354. PubMed ID: 31806190
[TBL] [Abstract][Full Text] [Related]
16. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effective analysis of seasonal influenza vaccine in elderly Chinese population].
Chen C; Liu GE; Wang MJ; Gao TF; Jia HP; Yang H; Feng LZ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):993-999. PubMed ID: 31607044
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis.
Wang Q; Jin H; Yang L; Jin H; Lin L
Infect Dis Poverty; 2023 Oct; 12(1):92. PubMed ID: 37821942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
